Washington, D.C –Today, Congressman Tom Marino (PA-10) voted in favor of H.R.1, the Tax Cuts & Jobs Act which passed the House of Representatives by a vote of 227-205.
Washington D.C. - Congressman Tom Marino (PA-10) issued the following statement after President Donald Trump announced the opioid crisis is a national public health emergency:
ICYMI: Rep. Marino Op-Ed: Truth is the Key to Solving the Opioid Crisis
October 25, 2017
““What is truth?” was Pontius Pilate’s famous question to Jesus. In our nation’s capital and the media, the answer seems to be “whatever the Washington Post says it is.”
ICYMI: Implausible Rep. Tom Marino led a Bipartisan Conspiracy to Worsen Drug Addiction Crisis
Bipartisan Drug Cartel?
The Wall Street Journal
The Editorial Board
October 24, 2017
Washington, D.C.— Congressman Tom Marino (R-PA-10) issued the following statement after requesting that President Donald Trump withdraw his name from consideration to lead the Office of National Drug Control Policy (ONDCP):
“Today I informed President Donald Trump of my intent to withdraw my name from any further consideration to lead ONDCP.
Washington, D.C.—Tomorrow at 1:00 p.m. Congressman Tom Marino (PA-10) will hold a hearing on anticompetitive behavior and the health care marketplace.
Washington, D.C.--Today, the U.S. Food and Drug Administration (FDA) held a public meeting to solicit input in areas where the FDA’s rules are being used in ways that create obstacles and delays. FDA Commissioner Scott Gottlieb, M.D., has shown a commitment to ensuring that generic manufacturers have access to promote competition.
Washington, D.C. — Today, the House passed H.R. 2810, the National Defense Authorization Act (NDAA) for Fiscal Year 2018 by a bipartisan vote of 344-81. Rep. Tom Marino (PA-10) voted in favor of the legislation and released the following statement:
Washington D.C.—Congressman Tom Marino (PA-10) issued the following statement following the Trump administration’s withdrawal of the Waters of the United States rule, commonly referred to as WOTUS.
Washington, D.C. -- Congressman Tom Marino (PA-10) and Congressman John Lewis (GA-05) reintroduced H.R. 2644, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2017.